Anti zmynd8

Manufactured by Proteintech

Anti-ZMYND8 is a laboratory-grade antibody product designed for research purposes. It is a tool used to detect and study the ZMYND8 protein, which plays a role in various cellular processes. The antibody can be utilized in standard immunological techniques, such as Western blotting, immunoprecipitation, and immunohistochemistry, to investigate the expression, localization, and interactions of the ZMYND8 protein.

Automatically generated - may contain errors

Lab products found in correlation

Anti flag, by Proteintech (2 mentions) Anti actb, by Proteintech (1 mentions) P cdk2 thr160, by Cell Signaling Technology (1 mentions) P rb1 s807 811, by Cell Signaling Technology (1 mentions) Anti h3k4me3, by Cell Signaling Technology (1 mentions) Anti ubiquitin, by Proteintech (1 mentions) Anti kdm5c, by Fortis Life Sciences (1 mentions) Anti hemagglutinin ha, by Proteintech (1 mentions) Anti rabbit antibodies, by Cell Signaling Technology (1 mentions)

Close spelling variants of this product

Anti-TM

2 protocols using anti zmynd8

Cell Cycle Regulation Protein Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

The primary antibodies used were anti-Cyclin D1/2 (Proteintech), anti-Cyclin E1/2 (Proteintech), anti-P21/P27 (Proteintech), anti-NKRF (Proteintech or Bethyl), anti-ZMYND8 (Proteintech), anti-ACTB (Proteintech), anti-FLAG (Proteintech), CDK2 (Proteintech), p-CDK2 Thr160 (Cell Signaling Technology), RB1 (Cell Signaling Technology), and p-RB1 S807/811 (Cell Signaling Technology). The HRP-linked anti-mouse (1/5000) and anti-rabbit antibodies (1/5000) were purchased from Cell Signaling Technology.

Jin X., Ge L.P., Li D.Q., Shao Z.M., Di G.H., Xu X.E, & Jiang Y.Z. (2020). LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer. Molecular Cancer, 19, 87.

+ Open protocol

+ Expand

Immunoblotting Assay for Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols

The following primary antibodies were used: anti-ZMYND8 (Proteintech), anti-ACTB (Actin Beta) (Proteintech), anti-hemagglutinin (HA; Proteintech), anti-Flag (Proteintech), anti-ubiquitin (Proteintech), anti-H3K4me3 (Cell Signaling Technology), anti-KDM5C (Bethyl), anti-ZNF592 (Bethyl), and anti-ZNF687 (Bethyl). The HRP-linked anti-mouse (1/5000) and anti-rabbit antibodies (1/5000) were purchased from Cell Signaling Technology.

Jin X., Xu X.E., Jiang Y.Z., Liu Y.R., Sun W., Guo Y.J., Ren Y.X., Zuo W.J., Hu X., Huang S.L., Shen H.J., Lan F., He Y.F., Hu G.H., Di G.H., He X.H., Li D.Q., Liu S., Yu K.D, & Shao Z.M. (2019). The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science Advances, 5(3), eaat9820.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!